Back to VIKING GLOBAL INVESTORS LP
VIKING GLOBAL INVESTORS LP stakes above 5%
This list is built from 4 structured filings (May 18, 2026 to Sep 16, 2026). Structured (XML) filing became mandatory in December 2024, and 335 older filings are plain documents that are not read here. A stake whose latest report is one of those does not appear, so this can be an incomplete list.
This filer has 63 structured large-holder filings. Only the newest 40 are read, so a stake whose latest report is older than 2025-09-24 is not shown.
36 filings could not be read and are not counted.
Stakes above 5%
3
by the latest report on each company
Schedule 13D stakes
1
may want to influence the company
Reported 5% or less
1
latest report says so
Reports read
4
filed May 18, 2026 to Sep 16, 2026
Stakes above 5%
The latest report on each company. The change compares it with the report before it on the same company, when that one was read.
| Company | Report | Share of class | Shares | Since its previous report | Filed |
|---|---|---|---|---|---|
| STANDARD BIOTOOLS INC.Common Stock | Schedule 13D | 15% | 58,651,170 | no earlier report read | Jun 12, 2026event Jun 6, 2026 |
| REGAL REXNORD CORPCommon Stock | Schedule 13GPassive investor (13d-1(c)) | 5.4% | 3,578,745 | no earlier report read | Sep 16, 2026event Sep 9, 2026 |
| Artiva Biotherapeutics, Inc.Common Stock | Schedule 13GPassive investor (13d-1(c)) | 5.4% | 2,604,166 | no earlier report read | May 18, 2026event May 11, 2026 |
Reported 5% or less (1)
On these companies the latest report says the stake is 5% or less. That can mean it sold, and it can also mean the shares moved to a related entity, so it is not shown as a sale.
| Company | Report | What it says | Its previous report | Filed |
|---|---|---|---|---|
| BridgeBio Pharma, Inc.Common Stock | Schedule 13D/A 12 | Reports 5% | not read | Jul 10, 2026 |